Pfizer's Obesity Pill Disappointed. Biotech Rivals Are Rubbing Their Hands.
Pfizer expects the market for new obesity pills to be $90 billion per year. Lilly, Novo, and many biotechs hope to claim chunks of it.
Source: marketwatch.com
Stay updated with breaking news from Roche Holdingannounced. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer expects the market for new obesity pills to be $90 billion per year. Lilly, Novo, and many biotechs hope to claim chunks of it.